STOCK TITAN
  1. Home
  2. SEC Filings
  3. VICR
  4. [144] VICOR CORP SEC Filing

VICR: Multiple Rule 144 Share Sales Reported

VICR discloses multiple Rule 144/10b5-1 transactions in its Common stock, showing repeated planned sales by an individual and institutional holders.

Filing Impact
(Neutral)
Filing Sentiment

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment worksHow the balance works

Form Type
144

Rhea-AI Filing Summary

VICR discloses multiple Rule 144/10b5-1 transactions in its Common stock, showing repeated planned sales by an individual and institutional holders. The filing lists numerous 10b5-1 sales by Patrizio Vinciarelli across March–June 2026, and hospital-related dispositions.

The excerpt includes examples of transactions such as 50,000 shares sold on April 15, 2026 for $9,660,511.00 and 20,000 shares with an aggregate value of $5,499,400.00 referenced alongside an outstanding share count of 33,863,689 shares as of 06/09/2026.

Insights

Routine, pre-arranged insider dispositions are documented with multiple 10b5-1 executions.

The filing lists repeated 10b5-1 sales by Patrizio Vinciarelli across March–June 2026, plus institutional holder disposals. The transactions are described with share counts and gross proceeds for each trade.

Examples shown include a 50,000-share sale on 04/15/2026 for $9,660,511.00 and a 20,000-share entry linked to $5,499,400.00; subsequent filings or Form 4s may provide additional attribution and post-sale holdings.

Illustrative trade 50,000 shares sale on 04/15/2026
Proceeds (example) $9,660,511.00 gross proceeds for 50,000 shares on 04/15/2026
Illustrative trade 20,000 shares listed in securities line associated with 06/09/2026
Associated dollar figure $5,499,400.00 amount shown alongside 20,000-share entry
Shares outstanding 33,863,689 shares as of 06/09/2026
Other example proceeds $6,430,096.00 proceeds for a 20,000-share sale on 06/01/2026 shown in the excerpt
10b5-1 regulatory
"10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Founders Shares market
"Common | 11/10/1981 | Founders Shares"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
Rule 144 regulatory
"144: Securities To Be Sold"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the VICR Form 144 filing disclose?
It lists Rule 144/10b5-1 sales of Common shares. The excerpt records multiple dated sales by Patrizio Vinciarelli and institutional holders, with per-transaction share counts and gross proceeds shown for trades between March and June 2026.

How many shares are shown as outstanding in the filing for VICR?
The filing shows 33,863,689 shares outstanding as of 06/09/2026. That figure appears on the securities line alongside a 20,000-share entry and an associated dollar amount in the excerpt.

Who executed the repeated 10b5-1 sales in the VICR excerpt?
Patrizio Vinciarelli is the repeatedly named seller under 10b5-1 plans. The excerpt lists many dated 10b5-1 sales by Vinciarelli, with multiple trades of 20,000–50,000 shares across March through June 2026.

Do the Form 144 entries show transaction proceeds for each sale?
Yes, per-transaction dollar amounts are provided. The excerpt pairs share counts and dates with gross proceeds (for example, $9,660,511.00 for 50,000 shares on 04/15/2026), listed next to each sale line.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Accepted by SEC EDGAR

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

Keep reading

More on VICR

All VICR news

Trending in the feed

LQDA
Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics, Ensuring Continued Commercialization of YUTREPIA in PAH Open the live feed